Hydroxypyridinethione Inhibitors of Human Insulin‐Degrading Enzyme
- 31 March 2021
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 16 (11) , 1776-1788
Abstract
Insulin‐degrading enzyme (IDE) is a human mononuclear Zn2+‐dependent metalloenzyme that is widely regarded as the primary peptidase responsible for insulin degradation. Despite its name, IDE is also critically involved in the hydrolysis of several other disparate peptide hormones, including glucagon, amylin, and the amyloid β‐protein. As such, the study of IDE inhibition is highly relevant to deciphering the role of IDE in conditions such as type‐2 diabetes mellitus and Alzheimer disease. There have been few reported IDE inhibitors, and of these, inhibitors that directly target the active‐site Zn2+ ion have yet to be fully explored. In an effort to discover new, zinc‐targeting inhibitors of IDE, a library of ∼350 metal‐binding pharmacophores was screened against IDE, resulting in the identification of 1‐hydroxypyridine‐2‐thione (1,2‐HOPTO) as an effective Zn2+‐binding scaffold. Screening a focused library of HOPTO compounds identified 3‐sulfonamide derivatives of 1,2‐HOPTO as inhibitors of IDE (Ki values of ∼50 μM). Further structure‐activity relationship studies yielded several thiophene‐sulfonamide HOPTO derivatives with good, broad‐spectrum activity against IDE that have the potential to be useful pharmacological tools for future studies of IDE.Keywords
Funding Information
- National Institutes of Health (R01GM115617)
This publication has 43 references indexed in Scilit:
- Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based ApproachJournal of Medicinal Chemistry, 2010
- Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of InsulinPLOS ONE, 2010
- Chelator Fragment Libraries for Targeting MetalloproteinasesChemMedChem, 2010
- Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading EnzymeJournal of Biological Chemistry, 2009
- Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound ScreeningPLOS ONE, 2009
- Chapter 22 Structure, Function, and Regulation of Insulin‐Degrading Enzyme2009
- Molecular basis for the thiol sensitivity of insulin-degrading enzymeProceedings of the National Academy of Sciences, 2008
- Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysinCellular and Molecular Life Sciences, 2008
- Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanismNature, 2006
- Bacitracin: An inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenaseBiochemical and Biophysical Research Communications, 1981